Description of Collaborative Activity: |
CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). FDA and NIH are also collaborating with the World Health Organization and the Infectious Disease Society of America to assess the global utility of the CURE ID. With an $8.3 million grant from HHS ASPE;s Patient-Centered Outcomes Research Trust Fund, CURE ID is also being expanded to include case reports extracted automatically from electronic health records using the EDGE Tool. This will significantly increase the quantity of data included in CURE ID. The EDGE tool is currently being used for COVID-19 data and is now being expanded to capture data on sepsis and meningitis treatments. |
